Skip to main
SEPN

Septerna Inc (SEPN) Stock Forecast & Price Target

Septerna Inc (SEPN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Septerna Inc is positioned for substantial growth, reflected in its current enterprise value of approximately $430 million, which indicates significant upside potential of 8-10 times the share price if its partnership with Novoproves yields positive results. The company's management expresses confidence in executing Phase 1 trials more efficiently for candidates like SEP-786, leveraging their prior experience, which bodes well for future advancements in its drug development efforts. Additionally, the promising preclinical results for SEP-631, which has the potential to match the efficacy of Xolair and achieve blockbuster status, further enhance the company's outlook by suggesting that it may offer an improved therapeutic profile.

Bears say

Septerna Inc faces significant risks that could hinder its clinical development, particularly concerning delays in advancing its product candidates like SEP-631 and potential setbacks in clinical trials. The company's reliance on partnerships, especially with Novo Nordisk, adds further uncertainty, along with challenges in obtaining regulatory approvals and lower-than-anticipated market penetration rates for its therapies. Furthermore, concerns about long-term dilution risk and a recent transaction in the obesity sector highlight a potential valuation gap that may negatively impact investor sentiment.

Septerna Inc (SEPN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Septerna Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Septerna Inc (SEPN) Forecast

Analysts have given Septerna Inc (SEPN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, Septerna Inc (SEPN) has a Strong Buy consensus rating as of Jan 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Septerna Inc (SEPN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.